Cancer
Research conducted at Peking University Cancer Hospital and Institute has yielded promising results in the treatment of gastric cancer. The study, which has been peer-reviewed and published in JAMA Oncology, investigated the efficacy and safety of adding atezolizumab to trastuzumab plus chemotherapy in patients with locally advanced, HER2-positive gastric or
Cancer
Researchers from Memorial Sloan-Kettering Cancer Center have made significant progress in treating peritoneal carcinomatosis, a type of cancer that has significantly compromised patient survival. According to a recent study published in Cell Reports Medicine, targeted therapy using radionuclides such as alpha, beta, and Auger emitters delivered by antibodies is being
Cancer
A groundbreaking clinical trial conducted by the University of Leeds has revealed an innovative treatment regime for myeloma, a blood cancer that accounts for 1 in 50 new cancer diagnoses in the UK. The trial, led by Professor Gordon Cook, has demonstrated that a treatment combining a second stem cell
Cancer
Researchers from Tongji University have made a significant discovery in the fight against cancer, publishing a paper in the journal Theranostics detailing the use of macrophage membrane-encapsulated nanotherapeutics for targeted cancer therapy. According to the study, these nanotherapeutics display distinct characteristics such as avoiding premature leakage, tumor targeting ability, immune
Cancer
Researchers at Sichuan University have developed a promising strategy for anti-cancer treatment by combining the benefits of various mechanisms. This synergistic therapy utilizes nanocomposites to induce cytotoxicity in tumor cells, generating instantaneous high temperatures and promoting apoptotic cell death. The study, published in the Biomedical and Environmental Sciences journal, highlights
Cancer
A study published in the Hematological Oncology journal has shown that direct-acting antivirals (DAAs) can induce a favorable response in patients with non-Hodgkin lymphoma (NHL) associated with hepatitis C virus (HCV) infection. The study, conducted by researchers at the University of Texas MD Anderson Cancer Center, followed 9 patients who
Cancer
Researchers at the Huazhong University of Science and Technology in Wuhan, People's Republic of China, have conducted a study on the efficacy of combining anlotinib, a small molecule vascular endothelial growth factor inhibitor, with albumin-bound paclitaxel (nab-ptx) in treating advanced gastric cancer (AGC). The study found that this
Cancer
Lucey Lyne, an 18-year-old from Doncaster, has been battling Hodgkin Lymphoma since the age of 16. Despite undergoing intensive treatments, including 24 weeks of chemotherapy, four weeks of radiotherapy, and a stem cell transplant, Lucey relapsed and needed a donor transplant. Fortunately, a perfect stem cell match was found in
Cancer
The University of Manchester recently released a study on the history of the research and development pipeline for anticancer drugs at pharmaceutical company Hoffmann-La Roche. The research analyzed the transformation from a chemistry-driven innovation model to one organized around molecular biology and collaborations with biotech companies. The study highlighted the
Cancer
A US-based health insurance company employee, suffering from stage 2 lymphoma, was denied the possibility of working from home despite a doctor's note advocating for remote work to minimize infection risk during chemotherapy. The employee's position was deemed "impossible to perform remotely" by the
